Oligodendrocyte myelin glycoprotein (OMgp): Evolution, structure and function

Brain Research Reviews

Volumn 45, Issue 2, 2004, Pages 115-124

  Vourc'h, Patrick ^a   Andres, Christian ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Development; Development and regeneration; Leucine rich repeat; MAG; Neuron; NF1 gene; Nogo; Oligodendrocyte; OMgp; Process outgrowth, growth cones, and sprouting

Indexed keywords

GLYCOPROTEIN; LEUCINE; MYELIN PROTEIN; PROTEIN NOGO A;

BRAIN DEVELOPMENT; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; EVOLUTION; GROWTH CONE; HUMAN; INTRON; MAMMAL; MOLECULAR EVOLUTION; MYELIN SHEATH; MYELINATION; NERVE CELL; NERVE FIBER GROWTH; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; EVOLUTION, MOLECULAR; GROWTH CONES; HUMANS; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; PROTEIN STRUCTURE, TERTIARY;

EID: 2442712937     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.01.003     Document Type: Review

References (113)

1. Ariga T., et al. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy. J. Biol. Chem. 262(2):1987;848-853
2. Autism, I.M.G.S.A.C., Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. PG - 973-82 (2001).
3. Bagri A., Tessier-Lavigne M. Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. Adv. Exp. Med. Biol. 515:2002;13-31
4. Bartsch U., et al. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron. 15(6):1995;1375-1381
5. Bastmeyer M., et al. Growth of regenerating goldfish axons is inhibited by rat oligodendrocytes and CNS myelin but not but not by goldfish optic nerve tract oligodendrocytelike cells and fish CNS myelin. J. Neurosci. 11(3):1991;626-640
6. Becker T., et al. Readiness of zebrafish brain neurons to regenerate a spinal axon correlates with differential expression of specific cell recognition molecules. J. Neurosci. 18(15):1998;5789-5803
7. Belachew S., et al. Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J. Neurosci. 22(19):2002;8553-8562
8. Bernard C.C., et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75(2):1997;77-88
9. Bongarzone E.R. Induction of oligodendrocyte fate during the formation of the vertebrate neural tube. Neurochem. Res. 27(11):2002;1361-1369
10. Bregman B.S., et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378(6556):1995;498-501
11. Campagnoni A.T. Molecular biology of myelin proteins from the central nervous system. J. Neurochem. 51(1):1988;1-14
12. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1(1):1988;85-96
13. Caroni P., Savio T., Schwab M.E. Central nervous system regeneration: oligodendrocytes and myelin as non-permissive substrates for neurite growth. Prog. Brain Res. 78:1988;363-370
14. Cawthon R.M., et al. Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics. 7(4):1990;555-565
15. Chelly J., Mandel J.L. Monogenic causes of X-linked mental retardation. Nat. Rev., Genet. 2(9):2001;669-680
16. Chen M.S., et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403(6768):2000;434-439
17. Chisholm A., Tessier-Lavigne M. Conservation and divergence of axon guidance mechanisms. Curr. Opin. Neurobiol. 9(5):1999;603-615
18. David S., Aguayo A.J. Axonal elongation into peripheral nervous system and quot; bridges and quot; after central nervous system injury in adult rats. Science. 214(4523):1981;931-933
19. Davies A.M. Regulation of neuronal survival and death by extracellular signals during development. EMBO J. 22(11):2003;2537-2545
20. DeBellard M.E., et al. Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. Mol. Cell. Neurosci. 7(2):1996;89-101
21. de Castro F. Chemotropic molecules: guides for axonal pathfinding and cell migration during CNS development. News Physiol. Sci. 18:2003;130-136
22. Dechant G., Barde Y.A. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat. Neurosci. 5(11):2002;1131-1136
23. Dickson B.J. Molecular mechanisms of axon guidance. Science. 298(5600):2002;1959-1964
24. Domeniconi M., et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 35(2):2002;283-290
25. Dorschner M.O., et al. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum. Mol. Genet. 9(1):2000;35-46
26. Fournier A.E., Strittmatter S.M. Repulsive factors and axon regeneration in the CNS. Curr. Opin. Neurobiol. 11(1):1999;89-94
27. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409(6818):2001;341-346
28. Fournier A.E., et al. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J. Neurosci. 22(20):2002;8876-8883
29. Friedman J.M. Epidemiology of neurofibromatosis type 1. Am. J. Med. Genet. 89(1):1999;1-6
30. Fruttiger M., et al. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 7(3):1995;511-515
31. Girault J.A., Peles E. Development of nodes of Ranvier. Curr. Opin. Neurobiol. 12(5):2002;476-485
32. GrandPre T., et al. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403(6768):2000;439-444
33. Gupta S. Deficiency of monoclonal antibody-defined NK Cells (HNK-1+) in primary immunodeficiency disorders. Immunol. Lett. 5(6):1982;327-329
34. Gutmann D.H., Collins F.S. Neurofibromatosis type 1. Beyond positional cloning. Arch. Neurol. 50(11):1993;1185-1193
35. Gutmann D.H., et al. Mouse models of human cancer consortium symposium on nervous system tumors. Cancer Res. 63(11):2003;3001-3004
36. Habib A.A., et al. The OMgp gene, a second growth suppressor within the NF1 gene. Oncogene. 16(12):1998;1525-1531
37. Habib A.A., et al. Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J. Neurochem. 1998;1704-1711
38. Hamasaki T., et al. Neuronal cell migration for the developmental formation of the mammalian striatum. Brain Res. Rev. 41(1):2003;1-12
39. Hirose S., Mitsudome A. X-linked mental retardation and epilepsy: pathogenetic significance of ARX mutations. Brain Dev. 25(3):2003;161-165
40. Huang C.J., et al. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line. Int. J. Dev. Neurosci. 20(3-5):2002;289-296
41. Huang Z., Tang X.M., Cambi F. Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Mol. Cell. Neurosci. 19(2):2002;250-262
42. Huber A.B., Schwab M.E. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol. Chem. 381(5-6):2000;407-419
43. Huber A.B., et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22(9):2002;3553-3567
44. Hunt D., Coffin R.S., Anderson P.N. The Nogo receptor, its ligands and axonal regeneration in the spinal cord: a review. J. Neurocytol. 31(2):2002;93-120
45. Jenne D.E., et al. A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. Genomics. 66(1):2000;93-97
46. Jenne D.E., et al. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am. J. Hum. Genet. 69(3):2001;516-527
47. Johnson P.W., et al. Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron. 3(3):1989;377-385
48. Johnson M.R., et al. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol. Cell. Biol. 14(1):1994;641-645
49. Kajava A.V. Structural diversity of leucine-rich repeat proteins. J. Mol. Biol. 277(3):1998;519-527
50. Kayes L.M., et al. Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J. Med. Genet. 29(10):1992;686-690
51. Kehrer-Sawatzki H., et al. Genomic characterization of the Neurofibromatosis Type 1 gene of Fugu rubripes. Gene. 222(1):1998;145-153
52. Kim J.E., et al. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron. 38(2):2003;187-199
53. Klinger M., et al. Identification of Nogo-66 Receptor (NgR) and Homologous Genes in Fish. Mol. Biol. Evol. 29:2003;29
54. Kobe B., Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struck. Biol. 11(6):2001;725-732
55. Kottis V., et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82(6):2002;1566-1569
56. Kullander K., Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev., Mol. Cell Biol. 3(7):2002;475-486
57. Laszkiewicz I., et al. Structural characterization of myelin-associated glycoprotein gene core promoter. J. Neurosci. Res. 50(6):1997;928-936
58. Li M., et al. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. J. Neurosci. Res. 46(4):1996;404-414
59. Li Q., et al. Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene. 20(30):2001;3929-3936
60. Lim Y.P., et al. Growth factors stimulate tyrosine dephosphorylation of p75 and its dissociation from the SH2 domain of Grb2. J. Biol. Chem. 272(47):1997;29892-29898
61. Liu B.P., et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 297(5584):2002;1190-1193
62. Mbarek O., et al. Association study of the NF1 gene and autistic disorder. Am. J. Med. Genet. 88(6):1999;729-732
63. McCormick F. Ras signaling and NF1. Curr. Opin. Genet. Dev. 5(1):1995;51-55
64. McKeon R.J., et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11(11):1991;3398-3411
65. McKerracher L., et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13(4):1994;805-811
66. Mikol D.D., Stefansson K. A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J. Cell Biol. 106(4):1988;1273-1279
67. Mikol D.D., Gulcher J.R., Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 110(2):1990;471-479
68. Mikol D.D., et al. Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein. J. Cell Biol. 111(6 Pt. 1):1990;2673-2679
69. Mikol D.D., et al. The oligodendrocyte-myelin glycoprotein of mouse: primary structure and gene structure. Genomics. 17(3):1993;604-610
70. Miller R.H. Regulation of oligodendrocyte development in the vertebrate CNS. Prog. Neurobiol. 67(6):2002;451-467
71. Mukhopadhyay G., et al. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13(3):1994;757-767
72. Ng C.E., Tang B.L. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration. J. Neurosci. Res. 67(5):2002;559-565
73. Niederost B.P., et al. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J. Neurosci. 19(20):1999;8979-8989
74. O'Connell P., et al. The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations. Genomics. 7(4):1990;547-554
75. Oertle T., et al. A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J. 17(10):2003;1238-1247
76. Oertle T., et al. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J. Mol. Biol. 325(2):2003;299-323
77. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am. J. Med. Genet. 89(1):1999;45-52
78. Pignot V., et al. Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J. Neurochem. 85(3):2003;717-728
79. Prinjha R., et al. Inhibitor of neurite outgrowth in humans. Nature. 403(6768):2000;383-384
80. Puschel A.W. The function of neuropilin/plexin complexes. Adv. Exp. Med. Biol. 515:2002;71-80
81. Quarles R.H. Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell. Mol. Life Sci. 59(11):2002;1851-1871
82. Riva P., et al. NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am. J. Hum. Genet. 66(1):2000;100-109
83. Saavedra R.A., et al. The myelin proteins of the shark brain are similar to the myelin proteins of the mammalian peripheral nervous system. J. Mol. Evol. 29(2):1989;149-156
84. Savio T., Schwab M.E. Rat CNS white matter, but not gray matter, is nonpermissive for neuronal cell adhesion and fiber outgrowth. J. Neurosci. 9(4):1989;1126-1133
85. Schachner M., Bartsch U. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia. 29(2):2000;154-165
86. Simonen M., et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron. 38(2):2003;201-211
87. Slavin A.J., et al. Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev. Neurosci. 19(1):1997;69-78
88. Spillmann A.A., et al. Identification and characterization of a bovine neurite growth inhibitor (bNI-220). J. Biol. Chem. 273(30):1998;19283-19293
89. Spiryda L.B. Myelin protein zero and membrane adhesion. J. Neurosci. Res. 54(2):1998;137-146
90. Temple S., Raff M.C. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell. 44(5):1986;773-779
91. Tissir F., Goffinet A.M. Reelin and brain development. Nat. Rev. Neurosci. 4(6):2003;496-505
92. Tokumoto Y.M., Tang D.G., Raff M.C. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J. 20(18):2001;5261-5268
93. Tozaki H., et al. Expression of Nogo protein by growing axons in the developing nervous system. Mol. Brain Res. 104(2):2002;111-119
94. Upadhyaya M., et al. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum. Genet. 102(5):1998;591-597
95. Viskochil D., et al. The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. Mol. Cell. Biol. 11(2):1991;906-912
96. Vourc'h P., et al. The oligodendrocyte-myelin glycoprotein gene is highly expressed during the late stages of myelination in the rat central nervous system. Dev. Brain Res. 144(2):2003;159-168
97. Vourc'h P., et al. Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor. J. Neurochem. 85(4):2003;889-897
98. Vourc'h P., et al. Molecular analysis of the oligodendrocyte myelin glycoprotein ene in autistic disorder. Neurosci. Lett. 338(2):2003;115-118
99. Waehneldt T.V. Phylogeny of myelin proteins. Ann. N.Y. Acad. Sci. 605:1990;15-28
100. Waehneldt T.V., Matthieu J.M., Jeserich G. Major central nervous system myelin glycoprotein of the African lungfish (Protopterus dolloi) cross-reacts with myelin proteolipid protein antibodies, indicating a close phylogenetic relationship with amphibians. J. Neurochem. 46(5):1986;1387-1391
101. Wang K.C., et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417(6892):2002;941-944
102. Wang K.C., et al. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 420(6911):2002;74-78
103. Wanner M., et al. Reevaluation of the growth-permissive substrate properties of goldfish optic nerve myelin and myelin proteins. J. Neurosci. 15(11):1995;7500-7508
104. Wolswijk G., Riddle P.N., Noble M. Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells. Glia. 4(5):1991;495-503
105. Wong S.T., et al. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5(12):2002;1302-1308
106. Xu G.F., et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 62(3):1990;599-608
107. Yamamoto S., et al. Mice deficient in nervous system-specific carbohydrate epitope HNK-1 exhibit impaired synaptic plasticity and spatial learning. J. Biol. Chem. 277(30):2002;27227-27231
108. Yamashita T., Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 6(5):2003;461-467
109. Yamashita T., Tucker K.L., Barde Y.A. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron. 24(3):1999;585-593
110. Yamashita T., Higuchi H., Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157(4):2002;565-570
111. Yoshida M., Colman D.R. Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin. Neuron. 16(6):1996;1115-1126
112. Zalc B., Colman D.R. Origins of vertebrate success. Science. 288(5464):2000;271-272
113. Zheng B., et al. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron. 38(2):2003;213-224